HMGB1 and Sepsis: At the same time, targeting HMGB1 with either antibodies or specific antagonists has been demonstrated to blunt inflammatory response and confer protective effects in animal models, including lethal endotoxemia or sepsis, collagen-induced arthritis, and ischemia-reperfusion induced tissue injury [5], [11], [12], [13].